Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXS8XL
|
||||
| Drug Name |
(1R)-1-(2-((S)-4-(6-fluoronaphthalen-1-yl)-2-methylpiperazin-1-yl)ethyl)-1,3,7,7a-tetrahydroisobenzofuran-5-carboxamide
|
||||
| Synonyms |
CHEMBL233212
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H30FN3O2
|
||||
| Canonical SMILES |
C[C@H]1CN(CCN1CC[C@H]2OCC3=CC(=CCC23)C(=O)N)c4cccc5cc(F)ccc45
|
||||
| InChI |
InChI=1S/C26H30FN3O2/c1-17-15-30(24-4-2-3-18-14-21(27)6-8-22(18)24)12-11-29(17)10-9-25-23-7-5-19(26(28)31)13-20(23)16-32-25/h2-6,8,13-14,17,23,25H,7,9-12,15-16H2,1H3,(H2,28,31)/t17-,23?,25+/m0/s1
|
||||
| InChIKey |
TZGHJRPUBWXMCC-PBGLVDLSSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.